This brand name is authorized in United States.
The drug SKELAXIN contains one active pharmaceutical ingredient (API):
1
|
Metaxalone
UNII
1NMA9J598Y - METAXALONE
|
|
Metaxalone is an oxazolidinone with centrally-acting skeletal muscle relaxant properties. Although the exact mechanism through which metaxalone exerts its effect is largely unknown, it might be due to general central nervous system (CNS) depression. Metaxalone has no direct effect on the contractile mechanisms of striated muscle, the motor end plate, or the nerve fiber. |
Below package inserts are available for further reading:
| Document | Type | Information Source | |
|---|---|---|---|
| SKELAXIN Tablet | MPI, US: SPL/Old | FDA, National Drug Code (US) |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| US | FDA, National Drug Code | 55289-736, 60793-136 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.